Correlation Between Duopharma Biotech and MSCM Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and MSCM Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and MSCM Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duopharma Biotech Bhd and MSCM Holdings Bhd, you can compare the effects of market volatilities on Duopharma Biotech and MSCM Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of MSCM Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and MSCM Holdings.

Diversification Opportunities for Duopharma Biotech and MSCM Holdings

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Duopharma and MSCM is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and MSCM Holdings Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MSCM Holdings Bhd and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with MSCM Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MSCM Holdings Bhd has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and MSCM Holdings go up and down completely randomly.

Pair Corralation between Duopharma Biotech and MSCM Holdings

Assuming the 90 days trading horizon Duopharma Biotech is expected to generate 189.36 times less return on investment than MSCM Holdings. But when comparing it to its historical volatility, Duopharma Biotech Bhd is 19.91 times less risky than MSCM Holdings. It trades about 0.01 of its potential returns per unit of risk. MSCM Holdings Bhd is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1.50  in MSCM Holdings Bhd on November 2, 2024 and sell it today you would lose (0.50) from holding MSCM Holdings Bhd or give up 33.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Duopharma Biotech Bhd  vs.  MSCM Holdings Bhd

 Performance 
       Timeline  
Duopharma Biotech Bhd 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Duopharma Biotech Bhd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
MSCM Holdings Bhd 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MSCM Holdings Bhd are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, MSCM Holdings disclosed solid returns over the last few months and may actually be approaching a breakup point.

Duopharma Biotech and MSCM Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duopharma Biotech and MSCM Holdings

The main advantage of trading using opposite Duopharma Biotech and MSCM Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, MSCM Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MSCM Holdings will offset losses from the drop in MSCM Holdings' long position.
The idea behind Duopharma Biotech Bhd and MSCM Holdings Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets